Gsk (GSK) EV to EBITDA (2009 - 2026)
Gsk's (GSK) EV to EBITDA stood at 5.31 in the quarter ended Mar 31, 2026, down 27.3% from 7.30 a year earlier but up 7.3% from the prior quarter.
Powered by 
Analysis
Gsk (GSK) EV to EBITDA (2009 - 2026) Analysis & Trends
On a TTM basis, Gsk's EV to EBITDA came in at 4.65 as of Mar 31, 2026, down 23.3% year-over-year; for the year ended Dec 31, 2025, it came in at 6.52, down 13.3% from the prior year.
- Across earlier years, EV to EBITDA came in at 7.52 in the year ended Dec 31, 2024 (+34.0%), 5.61 in the year ended Dec 31, 2023 (-3.4%), 5.81 in the year ended Dec 31, 2022 (-37.1%) and 9.23 in the year ended Dec 31, 2021 (-24.9%).
- Quarterly EV to EBITDA has ranged from 4.95 in the quarter ended Dec 31, 2025 to 10.97 in the quarter ended Dec 31, 2021 over the past five years.
- On a year-over-year basis, EV to EBITDA rose in 1 of the last four quarters, with an average decline of 17.0%.
- Peak year-over-year performance for EV to EBITDA in the last five years was growth of 65.0% in the quarter ended Dec 31, 2021, against a decline of 33.6% in the quarter ended Mar 31, 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.17 Bn | 1,237.79 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 660.04 Bn | 579.90 Bn | 17.30 Bn |
| 3 | AbbVie | 521.06 Bn | 494.17 Bn | 12.70 Bn |
| 4 | Merck | 370.60 Bn | 370.60 Bn | - |
| 5 | Novartis Ag | 311.97 Bn | 285.20 Bn | - |
| 6 | Astrazeneca | 288.69 Bn | 262.37 Bn | 12.86 Bn |
| 7 | Amgen | 252.29 Bn | 207.69 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 213.47 Bn | 213.47 Bn | - |
| 9 | Pfizer | 173.68 Bn | 120.32 Bn | 10.94 Bn |
| 10 | Gsk | 100.27 Bn | 83.11 Bn | 8.73 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 5.31 |
| Dec 31, 2025 | 4.95 |
| Mar 31, 2025 | 7.30 |
| Dec 31, 2024 | 6.70 |
| Mar 31, 2024 | 8.58 |
| Dec 31, 2023 | 6.66 |
| Mar 31, 2023 | 6.97 |
| Dec 31, 2022 | 7.63 |
| Mar 31, 2022 | 10.49 |
| Dec 31, 2021 | 10.97 |
| Mar 31, 2021 | 7.30 |
| Dec 31, 2020 | 6.65 |
| Mar 31, 2020 | 6.67 |
| Dec 31, 2019 | 8.28 |
| Sep 30, 2019 | 7.96 |
| Mar 31, 2019 | 8.03 |
| Dec 31, 2018 | 9.02 |
| Mar 31, 2018 | 11.12 |
| Dec 31, 2017 | 3.96 |
| Mar 31, 2017 | 3.99 |
API Access
Gsk EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();